It has been recently reported that prolonged exposition to irinotecan determined, in certain tumor cell lines, the up-regulation of γ-H2AX and phospho-Chk2, two DNA damage signal proteins able to enhance DNA repair thus reducing chemotherapy activity. The gene discussed is CHEK2; the disease is neoplasm.